Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Murray

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Frontiers in Oncology|December 20, 2024
A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot studyFrankie F Brown, Rebecca Oliver, Rachel Eddy, et al.
BMC Cancer|July 30, 2025
Non-invasive breath testing to detect colorectal cancer: protocol for a multicentre, case-control development and validation study (COBRA2 study)Michael G Fadel, James Murray, Georgia Woodfield, et al.
Organic Letters|July 27, 2023
Atroposelective Brønsted Acid-Catalyzed Photocyclization to Access Chiral <i>N</i>-Aryl Quinolones with Low Rotational BarriersAthimoolam Arunachalampillai, Prashantha Chandrappa, Alan Cherney, et al.
Brain, Behavior, and Immunity|March 19, 2024
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivoHarrison D Collier-Bain, Annabelle Emery, Adam J Causer, et al.
ACS Chemical Biology|April 18, 2025
Chemically Induced Nuclear Pore Complex Protein Degradation via TRIM21Xiaomei Li, Qingyang Wang, Anping Guo, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trialDavid L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Journal of Medicinal Chemistry|November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 InhibitorZoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Frontiers in Oncology|December 20, 2024
A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot studyFrankie F Brown, Rebecca Oliver, Rachel Eddy, et al.
BMC Cancer|July 30, 2025
Non-invasive breath testing to detect colorectal cancer: protocol for a multicentre, case-control development and validation study (COBRA2 study)Michael G Fadel, James Murray, Georgia Woodfield, et al.
Organic Letters|July 27, 2023
Atroposelective Brønsted Acid-Catalyzed Photocyclization to Access Chiral <i>N</i>-Aryl Quinolones with Low Rotational BarriersAthimoolam Arunachalampillai, Prashantha Chandrappa, Alan Cherney, et al.
Brain, Behavior, and Immunity|March 19, 2024
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivoHarrison D Collier-Bain, Annabelle Emery, Adam J Causer, et al.
ACS Chemical Biology|April 18, 2025
Chemically Induced Nuclear Pore Complex Protein Degradation via TRIM21Xiaomei Li, Qingyang Wang, Anping Guo, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trialDavid L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Journal of Medicinal Chemistry|July 25, 2019
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular ActivityZoltan Szlávik, Levente Ondi, Márton Csékei, et al.
BMJ Open|January 4, 2024
Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK studyEmma O'Dowd, Marko Berovic, Matthew Callister, et al.
Journal of Medicinal Chemistry|November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 InhibitorZoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Pageof 21